COVID-19 Clinical Studies
Active COVID-19 Clinical Studies Recruiting Volunteers
Fully Enrolled COVID-19 Clinical Studies in Follow-up
Monoclonal Antibodies Studies
Why Are We Continuing COVID-19 Research If Approvals Are Just Around the Corner?
There are over 7 billion people in the world. COVID-19 is affecting everyone, and vaccines are needed to end the pandemic. Now that we have vaccines that have proven to be very effective at preventing severe COVID-19 disease, why do we need to continue COVID-19 vaccine research?
There are three main reasons:
- If we find several vaccines that work, we can end the pandemic sooner.
- In addition to meeting the demand, we also need vaccines that can work for many kinds of people around the world.
- We still need more data over a longer period of time to answer key questions.
Read more about the 3 reasons for continuing research after some vaccines have been approved by the FDA.
COVID-19 Vaccines: What Do They Do?
Many people believe that the vaccines that receive Emergency Use Authorization (EUA) will prevent people from getting infected with coronavirus. We don’t know yet if that is true. The results show that these vaccines are really good at preventing an infection from turning into severe COVID-19 disease.
Even if you get a COVID-19 vaccine, you might still get a coronavirus infection.
This infographic provides detailed information about the recent COVID-19 vaccines that have received Emergency Use Authorization, including:
- What we know about their effectiveness,
- What we’re still trying to learn about the vaccines, and
- What the vaccines can do for you as well as what we all need to continue doing in order to protect ourselves and others from coronavirus infection.
View the infographic, COVID-19 Vaccines: What Do They Do?
Interested in volunteering for a COVID-19 Prevention Clinical Study?
Selecting the button below will take you to the CoVPN Volunteer Screening Registry.
Or register by calling 1-866-288-1919.